These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1568313)

  • 41. The Medicare and Clinical Laboratories Improvement Act of 1967 proficiency testing requirements and its relationship to the private sector.
    Edinger SE
    Arch Pathol Lab Med; 1988 Apr; 112(4):357-62. PubMed ID: 3281630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholesterol operational process specifications for assuring the quality required by CLIA proficiency testing.
    Westgard JO; Wiebe DA
    Clin Chem; 1991 Nov; 37(11):1938-44. PubMed ID: 1934469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of legislation (CLIA'88) on setting quality specifications for US laboratories.
    Ehrmeyer SS; Laessig RH
    Scand J Clin Lab Invest; 1999 Nov; 59(7):563-7. PubMed ID: 10667700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review of actual proficiency-testing performance under CLIA '67 (March 14, 1990) rules: perspective from the first year's data.
    Lanphear BJ; Burmeister BJ; Ehrmeyer SS; Laessig RH; Hassemer DJ
    Clin Chem; 1992 Jul; 38(7):1254-9; discussion 1268-72. PubMed ID: 1623590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulations for implementing the Clinical Laboratory Improvement Amendments of 1988: a summary.
    MMWR Recomm Rep; 1992 Feb; 41(RR-2):1-17. PubMed ID: 1538689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Final CLIA regulations. Clinical Laboratory Improvement Amendments.
    Health Devices; 1992 Nov; 21(11):420-5. PubMed ID: 1428896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Continuous challenges in Japanese forensic toxicology practice: strategy to address specific goals].
    Kageura M
    Nihon Hoigaku Zasshi; 2002 Sep; 56(2-3):219-28. PubMed ID: 12415829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Verifying performance characteristics of quantitative analytical systems: calibration verification, linearity, and analytical measurement range.
    Killeen AA; Long T; Souers R; Styer P; Ventura CB; Klee GG
    Arch Pathol Lab Med; 2014 Sep; 138(9):1173-81. PubMed ID: 25171699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The FAA's postmortem forensic toxicology self-evaluated proficiency test program: the first seven years.
    Chaturvedi AK
    J Forensic Sci; 2000 Mar; 45(2):422-8. PubMed ID: 10782965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wisconsin Cytology Proficiency Testing Program. Results of voluntary testing in 1994.
    Smith MA; Shalkham JE; Inhorn SL
    Acta Cytol; 1997; 41(6):1681-9. PubMed ID: 9390124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CLIA program; approval of the College of American Pathologists--HCFA. Notice.
    Fed Regist; 1995 Feb; 60(27):7774-80. PubMed ID: 10141154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The contribution of proficiency testing to improving laboratory performance and ensuring quality patient care.
    Johnson PR
    Clin Leadersh Manag Rev; 2004; 18(6):335-41. PubMed ID: 15597555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The quality of laboratory testing today: an assessment of sigma metrics for analytic quality using performance data from proficiency testing surveys and the CLIA criteria for acceptable performance.
    Westgard JO; Westgard SA
    Am J Clin Pathol; 2006 Mar; 125(3):343-54. PubMed ID: 16613337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. California Association of Toxicologists proficiency testing program.
    Walberg CB
    Clin Toxicol; 1979; 14(2):199-203. PubMed ID: 436395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. European specifications for imprecision and inaccuracy compared with operating specifications that assure the quality required by US CLIA proficiency-testing criteria.
    Westgard JO; Seehafer JJ; Barry PL
    Clin Chem; 1994 Jul; 40(7 Pt 1):1228-32. PubMed ID: 8013091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Going GLP: Conducting Toxicology Studies in Compliance with Good Laboratory Practices.
    Carroll EE
    US Army Med Dep J; 2016; (3-16):64-9. PubMed ID: 27613211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of Proficiency Testing as a Tool to Improve Quality in Microbiology Laboratories.
    Stang HL; Anderson NL
    Clin Microbiol Newsl; 2013 Sep; 35(18):145-152. PubMed ID: 26726277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A regulatory model for clinical laboratories: an empirical evaluation.
    Peddecord KM
    Clin Chem; 1989 Apr; 35(4):691-700. PubMed ID: 2702758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Internal quality control, proficiency testing, and the clinical relevance of laboratory testing.
    Kafka MT
    Arch Pathol Lab Med; 1988 Apr; 112(4):449-53. PubMed ID: 3355347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and Clinical Laboratory Improvement Act Program fee collection--HCFA. Final rule with comment period.
    Fed Regist; 1993 Jan; 58(11):5215-37. PubMed ID: 10171356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.